LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

LLY

922.4

-0.08%↓

UNH

589.22

-0.85%↓

NVO

137.37

+0.29%↑

JNJ

166.55

+0.63%↑

ABBV

195.28

+0.62%↑

Inicio・Lista de Acciones・PTC Therapeutics Inc

PTC Therapeutics Inc

Abierto

Sector Salud

33.62 -1

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

33.45

Máximo

34.12

Métricas clave
By Trading Economics
Ingresos	-7.6M -99M
Ventas	-23M 187M
BPA	-1.29
Margen de beneficio	-53.122
Empleados	988
EBITDA	-47M -35M

Recomendaciones
By TipRanks
Recomendaciones	Comprar
Estimación a 12 meses	+17.68 upside

Dividendos
By Dow Jones
Próximas Ganancias	24 oct 2024

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	101M 2.7B
Apertura anterior	34.62
Cierre anterior	33.62

Noticias sobre sentimiento de mercado

By Acuity

54%

46%

272 / 365 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

31.6 / 35.99 Soporte y Resistencia

PTC Therapeutics Inc Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

25 ene 2024, 23:44 UTC

Acciones populares

Stocks to Watch: Intel, PTC Therapeutics, KLA

28 sept 2023, 23:57 UTC

Acciones populares

Stocks to Watch: Nike, Novo Integrated, PTC Therapeutics

Comparación entre iguales

Cambio de precio

PTC Therapeutics Inc Esperado

Precio Objetivo

By TipRanks

17.68% repunte

Estimación a 12 meses

Media 40 USD 17.68%

Máximo 64 USD

Mínimo 26 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para PTC Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

Comprar

Mantener

Vender

De acuerdo con 15 analistas que ofrecen calificaciones bursátiles a para PTC Therapeutics Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

31.6 / 35.99Soporte y Resistencia

Recent bullish events outweigh bearish events.

The bullish and bearish events are balanced.

Sentimiento

By Acuity

272 / 365 Clasificación en Salud

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de PTC Therapeutics Inc

PTC Therapeutics, Inc. is a science-driven global biopharmaceutical company. The Company is focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The Company's portfolio pipeline includes several commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focused on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The Company has two products, Translarna (ataluren) and Emflaza (deflazacort), for the treatment of Duchenne muscular dystrophy (DMD). It has a pipeline of gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS), including PTC-AADC for the treatment of Aromatic L-Amino Acid Decarboxylase (AADC).